33 results on '"Jiang, Dingyuan"'
Search Results
2. Prospect for near-infrared light-assisted therapy for spinal cord injury
- Author
-
Xu, Chang, Sun, Jiachen, Tian, Miaomiao, Cui, Jingwen, Jiang, Dingyuan, Deng, Hao, Li, Dan, and Mei, Xifan
- Published
- 2023
- Full Text
- View/download PDF
3. Small airway dysfunction in Chinese patients with idiopathic pulmonary fibrosis
- Author
-
Zhang, Xinran, Xie, Bingbing, Ban, Chenjun, Ren, Yanhong, Ye, Qiao, Zhu, Min, Liu, Yan, Zhang, Shu, Geng, Jing, Jiang, Dingyuan, and Dai, Huaping
- Published
- 2022
- Full Text
- View/download PDF
4. Clinical characteristics of hypersensitivity pneumonitis: non-fibrotic and fibrotic subtypes.
- Author
-
Chen, Xueying, Yang, Xiaoyan, Ren, Yanhong, Xie, Bingbing, Xie, Sheng, Zhao, Ling, Wang, Shiyao, Geng, Jing, Jiang, Dingyuan, Luo, Sa, He, Jiarui, Shu, Shi, Hu, Yinan, Zhu, Lili, Li, Zhen, Zhang, Xinran, Liu, Min, Dai, Huaping, Pan, Xiangxiang, and Wei, Peifang
- Published
- 2023
- Full Text
- View/download PDF
5. Zinc defends against Parthanatos and promotes functional recovery after spinal cord injury through SIRT3‐mediated anti‐oxidative stress and mitophagy.
- Author
-
Jiang, Dingyuan, Yang, Xu, Ge, Minghao, Hu, Hengshuo, Xu, Chang, Wen, Shan, Deng, Hao, and Mei, Xifan
- Subjects
- *
SPINAL cord injuries , *CENTRAL nervous system injuries , *ZINC - Abstract
Introduction: Spinal cord injury (SCI) is a central nervous system injury that is primarily traumatic and manifests as motor, sensory, and autonomic dysfunction below the level of damage. Our previous studies confirmed the ability of zinc to protect mitochondria, protect neurons and promote spinal cord recovery. However, the role of zinc in Parthanatos is unknown. Aim: We investigated the effects of zinc in Parthanatos from oxidative stress and mitophagy. We elucidated the role of SIRT3 in providing new ideas for treating spinal cord injury. The Results: Zinc protected SCI mice by regulating Parthanatos. On the one hand, zinc eliminated ROS directly through SIRT3 deacetylation targeting SOD2 to alleviate Parthanatos. On the other hand, zinc eliminated ROS indirectly through SIRT3‐mediated promotion of mitophagy to alleviate Parthanatos. Conclusion: Zinc defends against Parthanatos and promotes functional recovery after spinal cord injury through SIRT3‐mediated anti‐oxidative stress and mitophagy. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
6. External validation of the GAP model in Chinese patients with idiopathic pulmonary fibrosis.
- Author
-
Zhang, Xinran, Ren, Yanhong, Xie, Bingbing, Wang, Shiyao, Geng, Jing, He, Xuan, Jiang, Dingyuan, He, Jiarui, Luo, Sa, Wang, Xin, Song, Dingyun, Fan, Mingming, and Dai, Huaping
- Subjects
IDIOPATHIC pulmonary fibrosis ,CHINESE people ,MODEL validation ,LUNG transplantation ,DEATH rate - Abstract
Introduction: The GAP model was widely used as a simple risk "screening" method for patients with idiopathic pulmonary fibrosis (IPF). Objectives: We sought to validate the GAP model in Chinese patients with IPF to evaluate whether it can accurately predict the risk for mortality. Methods: A total of 212 patients with IPF diagnosed at China‐Japan Friendship Hospital from 2015 to 2019 were enrolled. The latest follow‐up ended in September 2022. Cumulative mortality of each GAP stage was calculated and compared based on Fine‐Gray models for survival, and lung transplantation was treated as a competing risk. The performance of the model was evaluated in terms of both discrimination and calibration. Results: The cumulative mortality in patients with GAP stage III was significantly higher than that in those with GAP stage I or II (Gray's test p < 0.0001). The Harrell c‐index for the GAP calculator was 0.736 (95% CI: 0.667–0.864). The discrimination for the GAP staging system were similar with that for the GAP calculator. The GAP model overestimated the mortality rate at 1‐ and 2‐year in patients classified as GAP stage I (6.90% vs. 1.77% for 1‐year, 14.20% vs. 6.78% for 2‐year). Conclusions: Our findings indicated that the GAP model overestimated the mortality rate in mild group. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
7. Interleukin-17A plays a key role in pulmonary fibrosis following Propionibacterium acnes –induced sarcoidosis-like inflammation.
- Author
-
Jiang, Dingyuan, Xiao, Huijuan, Zheng, Xiaofen, Dong, Run, Zhang, Hongbing, and Dai, Huaping
- Published
- 2023
- Full Text
- View/download PDF
8. Repeated Challenge With Propionibacterium Acnes-Induced Chronic Sarcoidosis With Pulmonary Fibrosis in C57BL/6 Mice
- Author
-
Jiang, Dingyuan, Dai, Huaping, and Huang, Xiaoxi
- Published
- 2016
- Full Text
- View/download PDF
9. The Expression and Role of IL-25 and Its Receptor in Idiopathic Pulmonary Fibrosis
- Author
-
Xu, Xuefeng, Geng, Jing, Li, Shuhong, Jiang, Dingyuan, Wang, Chen, and Dai, Huaping
- Published
- 2016
- Full Text
- View/download PDF
10. IL‐17A promotes lung fibrosis through impairing mitochondrial homeostasis in type II alveolar epithelial cells.
- Author
-
Xiao, Huijuan, Peng, Liang, Jiang, Dingyuan, Liu, Yuan, Zhu, Lili, Li, Zhen, Geng, Jing, Xie, Bingbing, Huang, Xiaoxi, Wang, Jing, Dai, Huaping, and Wang, Chen
- Subjects
PULMONARY fibrosis ,EPITHELIAL cells ,IDIOPATHIC pulmonary fibrosis ,MITOCHONDRIA ,HOMEOSTASIS ,MYOFIBROBLASTS - Abstract
The dysfunction of type II alveolar epithelial cells (AECIIs), mainly manifested by apoptosis, has emerged as a major component of idiopathic pulmonary fibrosis (IPF) pathophysiology. A pivotal mechanism leading to AECIIs apoptosis is mitochondrial dysfunction. Recently, interleukin (IL)‐17A has been demonstrated to have a pro‐fibrotic role in IPF, though the mechanism is unclear. In this study, we report enhanced expression of IL‐17 receptor A (IL‐17RA) in AECIIs in lung samples of IPF patients, which may be related to the accumulation of mitochondria in AECIIs of IPF. Next, we investigated this relationship in bleomycin (BLM)‐induced PF murine model. We found that IL‐17A knockout (IL‐17A−/−) mice exhibited decreased apoptosis levels of AECIIs. This was possibly a result of the recovery of mitochondrial morphology from the improved mitochondrial dynamics of AECIIs, which eventually contributed to alleviating lung fibrosis. Analysis of in vitro data indicates that IL‐17A impairs mitochondrial function and mitochondrial dynamics of mouse primary AECIIs, further promoting apoptosis. PTEN‐induced putative kinase 1 (PINK1)/Parkin signal‐mediated mitophagy is an important aspect of mitochondria homeostasis maintenance. Our data demonstrate that IL‐17A inhibits mitophagy and promotes apoptosis of AECIIs by decreasing the expression levels of PINK1. We conclude that IL‐17A exerts its pro‐fibrotic effects by inducing mitochondrial dysfunction in AECIIs by disturbing mitochondrial dynamics and inhibiting PINK1‐mediated mitophagy, thereby leading to apoptosis of AECIIs. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
11. Krebs von den Lungen‐6 levels in untreated idiopathic pulmonary fibrosis.
- Author
-
Jiang, Dingyuan, Xiao, Huijuan, Dong, Run, Geng, Jing, Xie, Bingbing, Ren, Yanhong, and Dai, Huaping
- Subjects
- *
IDIOPATHIC pulmonary fibrosis , *INTERSTITIAL lung diseases , *ANTINUCLEAR factors , *LUNG infections - Abstract
Background: Serum Krebs von den Lungen‐6 (KL‐6) has been reported to be elevated in patients with idiopathic pulmonary fibrosis (IPF). Objective: The aim of this study was to evaluate the diagnostic value of KL‐6 and whether the expression value of KL‐6 could indicate the severity of the disease in IPF patients. To address this question, it is necessary to see whether the patients' physical characteristics and other clinical conditions could affect the baseline KL‐6 level. Design We conducted a study of 100 patients who were diagnosed with IPF. Lung function, computed tomography (CT), and serological lab tests data were analyzed. Results: The tests showed that there is a significant elevation of KL‐6 in IPF patients compared with other interstitial lung disease (ILD) and healthy controls. It was noted that serum KL‐6 is a stable biomarker not affected by lung infection and smoking, though IPF patients with antinuclear antibody (ANA) showed higher KL‐6 levels. KL‐6, in conjunction with poor pulmonary function and higher radiological fibrosis scores, indicates the severity of the disease but not poor survival. Conclusions: It is identified that serum KL‐6 is a useful noninvasive biomarker to help improve the certainty of IPF diagnosis from other interstitial lung disease and assist evaluation of disease severity and prognosis. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
12. Recent developments in the pathobiology of lung myofibroblasts.
- Author
-
Jiang, Dingyuan, Dey, Tapan, and Liu, Gang
- Published
- 2021
- Full Text
- View/download PDF
13. Hydrogen inhalation attenuated bleomycin‐induced pulmonary fibrosis by inhibiting transforming growth factor‐β1 and relevant oxidative stress and epithelial‐to‐mesenchymal transition.
- Author
-
Gao, Li, Jiang, Dingyuan, Geng, Jing, Dong, Run, and Dai, Huaping
- Subjects
- *
PULMONARY fibrosis , *TRANSFORMING growth factors , *IDIOPATHIC pulmonary fibrosis , *OXIDATIVE stress , *RESPIRATORY therapy , *H2 control , *GLUTATHIONE peroxidase - Abstract
New Findings: •What is the central question of this study?The aim was to explore the effects and underlying mechanisms of H2 on bleomycin‐induced pulmonary fibrosis.•What are the main findings and its importance?Our results indicate that, in bleomycin‐induced pulmonary fibrosis, H2 inhalation attenuated oxidative stress and reversed the pulmonary epithelial‐to‐mesenchymal transition process by reducing reactive oxygen species production and inhibiting the expression of transforming growth factor‐β1, α‐smooth muscle actin and collagen I to improve fibrotic injury and exert anti‐fibrogenic effects. Thus, H2 inhalation has promising therapeutic potential as a useful adjuvant treatment for patients with idiopathic pulmonary fibrosis, which deserves further study and evaluation. Hydrogen (H2) can protect against tissue damage. The effect of H2 inhalation therapy on the pathogenesis of pulmonary fibrosis remains unknown. This study was designed to explore the effects and underlying mechanisms of H2 inhalation on bleomycin (BLM)‐induced pulmonary fibrosis. A rat model of pulmonary fibrosis was established with BLM. Rats were randomly divided into control and H2 inhalation groups. Haematoxylin and Eosin staining and Mason's Trichrome staining were performed to evaluate pulmonary fibrosis injury, inflammatory cell infiltration, structural disorder and collagen deposition. qRT‐PCR and western blot assays were used to determine the expression of TNF‐α, TGF‐β1, α‐SMA, E‐cadherin, N‐cadherin, vimentin, VEGF and collagen type I at both mRNA and protein levels. The contents of reactive oxygen species, TGF‐β1, TNF‐α, malondialdehyde and hydroxyproline were determined with biochemical test kits or ELISA kits. Bleomycin‐stimulated rats exhibited typical symptoms of pulmonary fibrosis, which featured an increase in collagen deposition, alveolitis, fibrosis and parenchymal structural disorder in the lung. However, BLM‐induced oxidative stress was attenuated by H2 inhalation therapy, which reduced the contents of reactive oxygen species, malondialdehyde and hydroxyproline, enhanced the activity of glutathione peroxidase and decreased the expression of TGF‐β1 and TNF‐α. In addition, H2 inhalation also inhibited BLM‐induced epithelial‐to‐mesenchymal transition by inhibiting TGF‐β1, increasing the expression level of the epithelial cell marker E‐cadherin, and decreasing the expression level of the mesenchymal cell marker vimentin in a time‐dependent manner. In addition, H2 inhalation downregulated α‐SMA expression and suppressed collagen I generation, exerting anti‐fibrogenic effects. Hydrogen inhalation therapy attenuates BLM‐induced pulmonary fibrosis by inhibiting TGF‐β1, relevant oxidative stress and epithelial‐to‐mesenchymal transition. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
14. Modeling alveolar injury using microfluidic co-cultures for monitoring bleomycin-induced epithelial/fibroblastic cross-talk disorder.
- Author
-
He, Jiarui, Chen, Weixing, Deng, Shijie, Xie, Lan, Feng, Juan, Geng, Jing, Jiang, Dingyuan, Dai, Huaping, and Wang, Chen
- Published
- 2017
- Full Text
- View/download PDF
15. miR-130b-3p Modulates Epithelial-Mesenchymal Crosstalk in Lung Fibrosis by Targeting IGF-1.
- Author
-
Li, Shuhong, Geng, Jing, Xu, Xuefeng, Huang, Xiaoxi, Leng, Dong, Jiang, Dingyuan, Liang, Jiurong, Wang, Chen, Jiang, Dianhua, and Dai, Huaping
- Subjects
PULMONARY fibrosis ,SOMATOMEDIN C ,TARGETED drug delivery ,MICRORNA ,EPITHELIAL cells ,MESENCHYMAL stem cells ,BIOLOGICAL crosstalk ,DIAGNOSIS - Abstract
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and usually lethal fibrotic lung disease with largely unknown etiology and pathogenesis. Evidence suggests microRNAs (miRNA) contribute to pathogenesis of IPF. In this study, we sought to identify miRNA expression signatures and determine the role of miR-130b-3p in lung fibrosis. The miRNA expression profile of the lungs from patients with IPF and normal donors was determined by Affymetrix microarray, and transcriptome with Affymetrix array. The functions and signal pathways as well as miRNA-mRNA networks were established by bioinformatics analysis. Luciferase assays and ELISA were used to confirm the miRNA target gene. The effect of miRNA-transfected epithelium on fibroblast activities was assessed using a co-culture system. The fibroblast activities were determined by qRT-PCR, western blotting, Transwell and BrdU assays. Seven miRNAs were significantly decreased in IPF lungs, with miR-130b-3p being the highest in the miRNA-mRNA network. Insulin-like growth factor (IGF-1) was a target gene of miR-130b-3p in the epithelium. miR-130b-3p inhibition in the epithelium induced collagen I expression and enhanced the proliferation and migration ability of fibroblast in co-culture systems, which mimicked the functions of exogenous IGF-1 on fibroblasts. Neutralizing IGF-1 with an antibody significantly reduced the modulatory effects of miR-130b-3p inhibitor-transfected epithelium on the activation of fibroblasts. Our results show that miR-130b-3p was downregulated in IPF lungs. miR-130b-3p downregulation contributed to the activation of fibroblasts and the dysregulated epithelial-mesenchymal crosstalk by promoting IGF-1 secretion from lung epithelium, suggesting a key regulatory role for this miRNA in preventing lung fibrosis. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
16. Phosphatase and tensin homolog deleted on chromosome 10 contributes to phenotype transformation of fibroblasts in idiopathic pulmonary fibrosis via multiple pathways.
- Author
-
Geng, Jing, Huang, Xiaoxi, Li, Ying, Xu, Xuefeng, Li, Shuhong, Jiang, Dingyuan, Liu, Zheng, and Dai, Huaping
- Published
- 2016
- Full Text
- View/download PDF
17. Down-regulation of USP13 mediates phenotype transformation of fibroblasts in idiopathic pulmonary fibrosis.
- Author
-
Jing Geng, Xiaoxi Huang, Ying Li, Xuefeng Xu, Shuhong Li, Dingyuan Jiang, Jiurong Liang, Dianhua Jiang, Chen Wang, Huaping Dai, Geng, Jing, Huang, Xiaoxi, Li, Ying, Xu, Xuefeng, Li, Shuhong, Jiang, Dingyuan, Liang, Jiurong, Jiang, Dianhua, Wang, Chen, and Dai, Huaping
- Subjects
BIOCHEMISTRY ,CELL differentiation ,CELL lines ,CELL physiology ,CELL motility ,CELLULAR signal transduction ,FIBROBLASTS ,FLUORESCENT antibody technique ,GENES ,GENETIC techniques ,LUNGS ,PHENOMENOLOGY ,METABOLISM ,PHOSPHATASES ,POLYMERASE chain reaction ,PROTEOLYTIC enzymes ,RESEARCH funding ,TIME ,WESTERN immunoblotting ,PHENOTYPES ,CASE-control method ,REVERSE transcriptase polymerase chain reaction ,OLIGONUCLEOTIDE arrays ,IDIOPATHIC pulmonary fibrosis ,GENE expression profiling ,PRECIPITIN tests - Abstract
Background: Idiopathic pulmonary fibrosis (IPF) is a fatal disease characterized by fibroblastic foci and progressive scarring of the pulmonary parenchyma. IPF fibroblasts display increased proliferation and enhanced migration and invasion, analogous to cancer cells. This transformation-like phenotype of fibroblasts plays an important role in the development of pulmonary fibrosis, but the mechanism for this is not well understood.Methods: In this study, we compared gene expression profiles in fibrotic lung tissues from IPF patients and normal lung tissues from patients with primary spontaneous pneumothorax using a cDNA microarray to examine the mechanisms involved in the pathogenesis of IPF. In a cDNA microarray, we found that USP13 was decreased in lung tissues from patients with IPF, which was further confirmed by results from immunohistochemistry and western blot assays. Then, we used RNA interference in MRC-5 cells to inhibit USP13 and evaluated its effects by western blot, real-time RT-PCR, bromodeoxyuridine incorporation, and transwell assays. We also used co-immunoprecipitation and immunofluorescence staining to identify the correlation between USP13 and PTEN in IPF.Results: USP13 expression levels were markedly reduced in fibroblastic foci and primary IPF fibroblast lines. The depletion of USP13 resulted in the transformation of fibroblasts into an aggressive phenotype with enhanced proliferative, migratory, and invasive capacities. Additionally, USP13 interacted with PTEN and mediated PTEN ubiquitination and degradation in lung fibroblasts.Conclusions: Down-regulation of USP13 mediates PTEN protein loss and fibroblast phenotypic change, and thereby plays a crucial role in IPF pathogenesis. [ABSTRACT FROM AUTHOR]- Published
- 2015
- Full Text
- View/download PDF
18. Imbalanced distribution of regulatory T cells and Th17.1 cells in the peripheral blood and BALF of sarcoidosis patients: relationship to disease activity and the fibrotic radiographic phenotype.
- Author
-
Zhang H, Jiang D, Zhu L, Zhou G, Xie B, Cui Y, Costabel U, and Dai H
- Subjects
- Humans, T-Lymphocytes, Regulatory, Bronchoalveolar Lavage Fluid, Lung pathology, Phenotype, Sarcoidosis, Idiopathic Pulmonary Fibrosis metabolism
- Abstract
Rationale: Sarcoidosis is a granulomatous interstitial lung disease involving a complex interplay among different cluster of differentiation 4 (CD4
+ ) thymus cell (T-cell) subsets. Originally described as a type 1 T-helper (Th1) inflammatory disease, recent evidence suggests that both effector and regulatory T-cell subgroups play a critical role in sarcoidosis, but this remains controversial., Objectives: We aimed to investigate the distribution of CD4+ T-cell subpopulations in sarcoidosis patients and its potential associations with clinical disease activity and a radiographic fibrotic phenotype., Methods: We measured the frequencies of regulatory T cells (Tregs), Th1, Th17, and Th17.1 cells in the peripheral blood and/or bronchoalveolar lavage fluid (BALF) of 62 sarcoidosis patients, 66 idiopathic pulmonary fibrosis (IPF) patients, and 41 healthy volunteers using flow cytometry. We also measured the changes in these T-cell subpopulations in the blood at the follow-up visits of 11 sarcoidosis patients., Measurements and Results: An increased percentage of Tregs was observed in the peripheral blood of sarcoidosis patients, with a positive association to disease activity and a fibrotic radiographic phenotype. We found a higher frequency of Tregs, a lower proportion of Th17.1 cells, and a lower ratio of Th17.1 cells to total Tregs in the peripheral blood of both active and fibrotic sarcoidosis patients, compared with IPF patients or healthy donors. In contrast, a lower frequency of Tregs and a higher proportion of Th17.1 cells was found in the BALF of sarcoidosis patients than in that of IPF patients. There was an imbalance of Tregs and Th17.1 cells between the peripheral blood and BALF in sarcoidosis patients. Following immunoregulatory therapy, the proportion of circulating Tregs in sarcoidosis patients decreased., Conclusion: A higher proportion of Tregs in the peripheral blood of sarcoidosis patients was related to disease activity, fibrotic phenotype, and the need for immunoregulatory therapy. The imbalanced distribution of Tregs and Th17.1 cells in patients' peripheral blood and BALF suggests that the lung microenvironment has an effect on the immunological pathogenesis of sarcoidosis. Therefore, further studies on the functional analysis of Tregs and Th17.1 cells in sarcoidosis patients are warranted., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Zhang, Jiang, Zhu, Zhou, Xie, Cui, Costabel and Dai.)- Published
- 2023
- Full Text
- View/download PDF
19. Case report: Corticosteroid-resistant acute fibrinous and organizing pneumonia with myelodysplastic syndrome.
- Author
-
Jiang D, Chen X, Li J, Zhao L, and Dai H
- Abstract
Acute fibrinous and organizing pneumonia (AFOP) is a lung disease with an unusual pathological pattern. The definitive diagnosis of AFOP relies on pathological evidence of intra-alveolar fibrin exudate, lymphoplasmacytic infiltrate, and the absence of a hyaline membrane. Furthermore, its etiology is difficult to confirm, and corticosteroids are usually effective. Herein, we report the case of a young male who presented with high fever, hemocytopenia, and consolidation in both lungs. The initial misdiagnosis was community-acquired pneumonia. Subsequently, a lung biopsy revealed abundant fibrin and fibroblast exudates in the alveolar spaces, indicating AFOP. In addition, bone marrow biopsy and karyotype analysis demonstrated that the patient simultaneously had myelodysplastic syndrome (MDS) and hemophagocytic lymphohistiocytosis. In this case, the AFOP was considered secondary to MDS; however, the disease did not respond to glucocorticoid treatment or chemotherapy. Hence, AFOP should be considered in patients with underlying hematological diseases, and early identification and diagnosis are important. Furthermore, the management of patients with severe AFOP requires further investigation., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Jiang, Chen, Li, Zhao and Dai.)
- Published
- 2023
- Full Text
- View/download PDF
20. Blood monocyte counts as a prognostic biomarker and predictor in Chinese patients with idiopathic pulmonary fibrosis.
- Author
-
Zhang X, Ren Y, Xie B, Ye Q, Ban C, Zhang S, Zhu M, Liu Y, Wang S, Geng J, He X, Jiang D, He J, Shu S, Luo S, Wang X, Song D, Fan M, Sun H, and Dai H
- Abstract
Objectives: We sought to evaluate the prognostic value of blood routine parameters and biochemical parameters, especially inflammation-related biomarkers, and establish an inflammation-related prognostic model in Chinese patients with idiopathic pulmonary fibrosis (IPF)., Material/methods: Patients diagnosed as IPF at Beijing Chaoyang Hospital and aged 40 years and older were consecutively enrolled from June 2000 to March 2015, and finally, a total of 377 patients were enrolled in the derivation cohort. The follow-up ended in December 2016. We used Cox proportional hazard model to calculate the hazard ratio (HR) and establish the prognostic model. The discrimination and calibration of the prognostic model were evaluated in an independent validation cohort enrolled from China-Japan Friendship Hospital between January 2015 and December 2019., Results: Multivariate analysis revealed that patients with elevated monocyte-to-red blood cell count ratio (MRR) and monocyte counts showed increased risk of mortality. The clinical-physiological-biomarker (CPB) index and CPB stage we established in this study were a significant predictor, and the C-index for CPB index and CPB stage in the validation cohort was 0.635 (95% CI: 0.558-0.712) and 0.619 (95% CI: 0.544-0.694), respectively. Patients in CPB stage III had the poorest survival., Conclusion: We developed and validated a new inflammation-related prognostic model (CPB index and CPB stage) which was integration of age, gender, FVC (%, predicted), DLCO (%, predicted), Charlson Comorbidity Index, and blood monocyte counts. This prediction model exhibited strong ability in predicting mortality in Chinese patients with IPF., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Zhang, Ren, Xie, Ye, Ban, Zhang, Zhu, Liu, Wang, Geng, He, Jiang, He, Shu, Luo, Wang, Song, Fan, Sun and Dai.)
- Published
- 2022
- Full Text
- View/download PDF
21. A transcriptomics-based meta-analysis identifies a cross-tissue signature for sarcoidosis.
- Author
-
Jiang Y, Jiang D, Costabel U, Dai H, and Wang C
- Abstract
Sarcoidosis is a granulomatous disease of unknown etiology, immunologically characterized by a Th1 immune response. Transcriptome-wide expression studies in various types of sarcoid tissues contributed to better understanding of disease mechanisms. We performed a systematic database search on Gene Expression Omnibus (GEO) and utilized transcriptomic data from blood and sarcoidosis-affected tissues in a meta-analysis to identify a cross-tissue, cross-platform signature. Datasets were further separated into training and testing sets for development of a diagnostic classifier for sarcoidosis. A total of 690 differentially expressed genes were identified in the analysis among various tissues. 29 of the genes were robustly associated with sarcoidosis in the meta-analysis both in blood and in lung-associated tissues. Top genes included LINC01278 ( P = 3.11 × 10
-13 ), GBP5 ( P = 5.56 × 10-07 ), and PSMB9 ( P = 1.11 × 10-06 ). Pathway enrichment analysis revealed activated IFN-γ, IL-1, and IL-18, autophagy, and viral infection response. IL-17 was observed to be enriched in peripheral blood specific signature genes. A 16-gene classifier achieved excellent performance in the independent validation data (AUC 0.711-0.964). This study provides a cross-tissue meta-analysis for expression profiles of sarcoidosis and identifies a diagnostic classifier that potentially can complement more invasive procedures., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Jiang, Jiang, Costabel, Dai and Wang.)- Published
- 2022
- Full Text
- View/download PDF
22. Targeting FSTL1 for Multiple Fibrotic and Systemic Autoimmune Diseases.
- Author
-
Li X, Fang Y, Jiang D, Dong Y, Liu Y, Zhang S, Guo J, Qi C, Zhao C, Jiang F, Jin Y, Geng J, Yang C, Zhang H, Wei B, Liang J, Wang C, Dai H, Zhou H, Jiang D, and Ning W
- Subjects
- Animals, Autoimmune Diseases drug therapy, Autoimmune Diseases pathology, Disease Models, Animal, Drug Discovery, Fibrosis, Follistatin-Related Proteins antagonists & inhibitors, Follistatin-Related Proteins genetics, Gene Expression, Humans, Idiopathic Pulmonary Fibrosis drug therapy, Idiopathic Pulmonary Fibrosis pathology, Mice, Molecular Targeted Therapy, Transforming Growth Factor beta1 metabolism, Autoimmune Diseases etiology, Autoimmune Diseases metabolism, Biomarkers, Disease Susceptibility, Follistatin-Related Proteins metabolism, Idiopathic Pulmonary Fibrosis etiology, Idiopathic Pulmonary Fibrosis metabolism
- Abstract
Follistatin-like 1 (FSTL1) is a matricellular protein that is upregulated during development and disease, including idiopathic pulmonary fibrosis (IPF), keloid, and arthritis. The profibrotic and pro-inflammatory roles of FSTL1 have been intensively studied during the last several years, as well as in this report. We screened and identified epitope-specific monoclonal neutralizing antibodies (nAbs) to functionally block FSTL1. FSTL1 nAbs attenuated bleomycin-induced pulmonary and dermal fibrosis in vivo and transforming growth factor (TGF)-β1-induced dermal fibrosis ex vivo in human skin. In addition, FSTL1 nAbs significantly reduced existing lung fibrosis and skin fibrosis in experimental models. FSTL1 nAbs exerted their potent antifibrotic effects via reduced TGF-β1 responsiveness and subsequent myofibroblast activation and extracellular matrix production. We also observed that FSTL1 nAbs attenuated the severity of collagen-induced arthritis in mice, which was accompanied by reduced inflammatory responses in vitro. Our findings suggest that FSTL1 nAbs are a promising new therapeutic strategy for the treatment of multiple organ fibrosis and systemic autoimmune diseases., (Copyright © 2020 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
23. Lung Myofibroblasts Promote Macrophage Profibrotic Activity through Lactate-induced Histone Lactylation.
- Author
-
Cui H, Xie N, Banerjee S, Ge J, Jiang D, Dey T, Matthews QL, Liu RM, and Liu G
- Subjects
- Animals, Cells, Cultured, Humans, Indoles pharmacology, Lung drug effects, Lung pathology, Macrophages, Alveolar drug effects, Macrophages, Alveolar pathology, Male, Mice, Mice, Inbred C57BL, Myofibroblasts drug effects, Myofibroblasts pathology, Pulmonary Fibrosis drug therapy, Pulmonary Fibrosis pathology, Pyridones pharmacology, Histones metabolism, Lactates metabolism, Lung metabolism, Macrophages, Alveolar metabolism, Myofibroblasts metabolism, Pulmonary Fibrosis metabolism
- Abstract
Augmented glycolysis due to metabolic reprogramming in lung myofibroblasts is critical to their profibrotic phenotype. The primary glycolysis byproduct, lactate, is also secreted into the extracellular milieu, together with which myofibroblasts and macrophages form a spatially restricted site usually described as fibrotic niche. Therefore, we hypothesized that myofibroblast glycolysis might have a non-cell autonomous effect through lactate regulating the pathogenic phenotype of alveolar macrophages. Here, we demonstrated that there was a markedly increased lactate in the conditioned media of TGF-β1 (transforming growth factor-β1)-induced lung myofibroblasts and in the BAL fluids (BALFs) from mice with TGF-β1- or bleomycin-induced lung fibrosis. Importantly, the media and BALFs promoted profibrotic mediator expression in macrophages. Mechanistically, lactate induced histone lactylation in the promoters of the profibrotic genes in macrophages, consistent with the upregulation of this epigenetic modification in these cells in the fibrotic lungs. The lactate inductions of the histone lactylation and profibrotic gene expression were mediated by p300, as evidenced by their diminished concentrations in p300-knockdown macrophages. Collectively, our study establishes that in addition to protein, lipid, and nucleic acid molecules, a metabolite can also mediate intercellular regulations in the setting of lung fibrosis. Our findings shed new light on the mechanism underlying the key contribution of myofibroblast glycolysis to the pathogenesis of lung fibrosis.
- Published
- 2021
- Full Text
- View/download PDF
24. Idiopathic Pulmonary Fibrosis Registry China study (PORTRAY): protocol for a prospective, multicentre registry study.
- Author
-
Xie B, Ren Y, Geng J, He X, Ban C, Wang S, Jiang D, Luo S, Chen Q, Liu M, Feng R, Zhao L, Dai H, and Wang C
- Subjects
- Bronchoalveolar Lavage Fluid, China epidemiology, Humans, Prospective Studies, Registries, Idiopathic Pulmonary Fibrosis diagnosis, Idiopathic Pulmonary Fibrosis epidemiology
- Abstract
Introduction: Idiopathic pulmonary fibrosis (IPF) is a progressive and lethal lung disease characterised by a fibrotic histological pattern found in usual interstitial pneumonia. Its causes, pathogenesis, clinical phenotype and molecular mechanisms are poorly defined. Large-scale, multicentre studies are warranted to better understand IPF as a disease in China, its associated risk factors, clinical characteristics, diagnosis, disease progression and treatment., Methods and Analysis: The Idiopathic Pulmonary Fibrosis Registry China Study (PORTRAY) is a prospective, multicentre registry study of patients with IPF in China. Eight hundred patients will be enrolled over a 36-month period and followed for at least 3 years to generate a comprehensive database on baseline characteristics and various follow-up parameters including patient-reported outcomes. Biological specimens will also be collected from patients to develop a library of blood, bronchoalveolar lavage fluid and lung biopsy samples, to support future research. As of 15 December 2019, 204 patients from 19 large medical centres with relatively high IPF diagnosis and treatment rates had been enrolled. Patient characteristics will be presented using descriptive statistics. The Kaplan-Meier method will be used for survival analyses. Repeated measures will be used to compare longitudinal changes in lung function, imaging and laboratory tests. Results following analysis have been projected to be available by July 2025., Ethics and Dissemination: The study protocol was reviewed and approved by the Institutional Review Board from all the study sites currently recruiting patients. Study results will be published in peer-reviewed journals., Trial Registration Number: NCT03666234., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2020
- Full Text
- View/download PDF
25. ATF4 Mediates Mitochondrial Unfolded Protein Response in Alveolar Epithelial Cells.
- Author
-
Jiang D, Cui H, Xie N, Banerjee S, Liu RM, Dai H, Thannickal VJ, and Liu G
- Subjects
- Alveolar Epithelial Cells physiology, Animals, Apoptosis physiology, Cell Line, Endoplasmic Reticulum Stress physiology, Humans, Idiopathic Pulmonary Fibrosis metabolism, Idiopathic Pulmonary Fibrosis physiopathology, Lung metabolism, Male, Mice, Mice, Inbred C57BL, Mitochondria physiology, Signal Transduction physiology, Activating Transcription Factor 4 metabolism, Alveolar Epithelial Cells metabolism, Mitochondria metabolism, Unfolded Protein Response physiology
- Abstract
Although endoplasmic reticulum (ER) unfolded protein response (UPR
ER ) is well known, mitochondrial unfolded protein response (UPRmt ) has not been recognized in alveolar epithelial cells. Furthermore, ER stress and mitochondrial dysfunction are frequently encountered in alveolar epithelial cells from an array of lung disorders. However, these two scenarios have been often regarded as separate mechanisms contributing to the pathogeneses. It is unclear whether there is interplay between these two phenomena or an integrator that couples these two signaling cascades in the stressed alveolar epithelial cells from those pathologies. In this study, we defined UPRmt in alveolar epithelial cells and identified ATF4 (activating transcription factor 4), but not ATF5, as the key regulator of UPRmt . We found that UPRER led to UPRmt and mitochondrial dysfunction in an ATF4-dependent manner. In contrast, mitochondrial stresses did not activate UPRER . We found that alveolar epithelial ATF4 and UPRmt were induced in aged mice with experimental pulmonary fibrosis as well as in patients with idiopathic pulmonary fibrosis. Finally, we found that the inducible expression of ATF4 in mouse alveolar epithelial cells aggravated pulmonary UPRmt , lung inflammation, body weight loss, and death upon bleomycin-induced lung injury. In conclusion, ER stress induces ATF4-dependent UPRmt and mitochondrial dysfunction, indicating a novel mechanism by which ER stress contributes to the pathogeneses of a variety of pulmonary disorders.- Published
- 2020
- Full Text
- View/download PDF
26. Monocyte-derived alveolar macrophage apolipoprotein E participates in pulmonary fibrosis resolution.
- Author
-
Cui H, Jiang D, Banerjee S, Xie N, Kulkarni T, Liu RM, Duncan SR, and Liu G
- Subjects
- Animals, Antibiotics, Antineoplastic toxicity, Apolipoproteins E genetics, Bleomycin toxicity, Bronchoalveolar Lavage Fluid, Collagen Type I, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Protein Binding, Pulmonary Fibrosis chemically induced, Pulmonary Fibrosis pathology, Apolipoproteins E metabolism, Macrophages, Alveolar metabolism, Monocytes metabolism, Pulmonary Fibrosis metabolism
- Abstract
Recent studies have presented compelling evidence that it is not tissue-resident, but rather monocyte-derived alveolar macrophages (TR-AMs and Mo-AMs, respectively) that are essential to development of experimental lung fibrosis. However, whether apolipoprotein E (ApoE), which is produced abundantly by Mo-AMs in the lung, plays a role in the pathogenesis is unclear. In this study, we found that pulmonary ApoE was almost exclusively produced by Mo-AMs in mice with bleomycin-induced lung fibrosis. We showed that, although ApoE was not necessary for developing maximal fibrosis in bleomycin-injured lung, it was required for the resolution of this pathology. We found that ApoE directly bound to Collagen I and mediated Collagen I phagocytosis in vitro and in vivo, and this process was dependent on low-density lipoprotein receptor-related protein 1 (LPR1). Furthermore, interference of ApoE/LRP1 interaction impaired the resolution of lung fibrosis in bleomycin-treated WT mice. In contrast, supplementation of ApoE promoted this process in ApoE-/- animals. In conclusion, Mo-AM-derived ApoE is beneficial to the resolution of lung fibrosis, supporting the notion that Mo-AMs may have distinct functions in different phases of lung fibrogenesis. The findings also suggest a potentially novel therapeutic target for treating lung fibrosis, to which effective remedies remain scarce.
- Published
- 2020
- Full Text
- View/download PDF
27. Inhibition of Glutaminase 1 Attenuates Experimental Pulmonary Fibrosis.
- Author
-
Cui H, Xie N, Jiang D, Banerjee S, Ge J, Sanders YY, and Liu G
- Subjects
- Animals, Benzeneacetamides pharmacology, Bleomycin toxicity, Cell Line, Collagen biosynthesis, Enzyme Induction, Glutaminase genetics, Lung enzymology, Male, Mice, Mice, Inbred C57BL, Molecular Targeted Therapy, Pulmonary Fibrosis chemically induced, Pulmonary Fibrosis enzymology, RNA Interference, RNA, Messenger biosynthesis, RNA, Small Interfering pharmacology, Thiadiazoles pharmacology, Transforming Growth Factor beta1 pharmacology, Fibroblasts enzymology, Glutaminase antagonists & inhibitors, Pulmonary Fibrosis drug therapy
- Abstract
It has been increasingly recognized lately that aberrant cellular metabolism plays an important role in the pathogenesis of pulmonary fibrosis. In our previous systemic studies, we found that human lung myofibroblasts undergo glutaminolytic reprogramming, which is mediated by an increased expression of glutaminase (Gls) 1. We showed that augmented glutaminolysis critically regulates collagen production by promoting its stabilization in human lung myofibroblasts. Our study indicates that lung fibroblast Gls1 is a promising therapeutic target for this disease. In this investigation, we primarily focused on delineating the in vivo role of fibroblast Gls1 in mouse models of pulmonary fibrosis and determining the efficacy of Gls1 inhibition in treating this pathology. We now show that fibroblast Gls1 is upregulated in fibrotic mouse lungs. We present evidence that mice with ablation of fibroblast Gls1 are protected from bleomycin-induced lung fibrosis. We show that the Gls1 inhibitor, CB-839, is therapeutically efficacious in treating both bleomycin- and transforming growth factor-β1-induced pulmonary fibrosis. Our study has thus established a solid rationale for advancing Gls1 inhibitors, particularly CB-839, to the next stage of testing in the treatment of this disease.
- Published
- 2019
- Full Text
- View/download PDF
28. Long noncoding RNA Malat1 regulates differential activation of macrophages and response to lung injury.
- Author
-
Cui H, Banerjee S, Guo S, Xie N, Ge J, Jiang D, Zörnig M, Thannickal VJ, and Liu G
- Subjects
- Acute Lung Injury diagnosis, Acute Lung Injury genetics, Animals, Bleomycin toxicity, Bronchoalveolar Lavage Fluid, Cell Differentiation genetics, Cell Differentiation immunology, Disease Models, Animal, Down-Regulation immunology, Fibrosis, Gene Knockdown Techniques, Humans, Lectins, C-Type immunology, Lipopolysaccharides administration & dosage, Lipopolysaccharides immunology, Lung cytology, Lung immunology, Macrophage Activation immunology, Macrophages, Alveolar metabolism, Male, Mice, Mice, Knockout, Monosaccharide Transport Proteins immunology, RNA, Long Noncoding genetics, Up-Regulation genetics, Up-Regulation immunology, Acute Lung Injury immunology, Lectins, C-Type genetics, Lung pathology, Macrophage Activation genetics, Macrophages, Alveolar immunology, Monosaccharide Transport Proteins genetics, RNA, Long Noncoding metabolism
- Abstract
Macrophage activation, i.e., classical M1 and the alternative M2, plays a critical role in many pathophysiological processes, such as inflammation and tissue injury and repair. Although the regulation of macrophage activation has been under extensive investigation, there is little knowledge about the role of long noncoding RNAs (lncRNAs) in this event. In this study, we found that lncRNA Malat1 expression is distinctly regulated in differentially activated macrophages in that it is upregulated in LPS-treated and downregulated in IL-4-treated cells. Malat1 knockdown attenuates LPS-induced M1 macrophage activation. In contrast, Malat1 knockdown enhanced IL-4-activated M2 differentiation as well as a macrophage profibrotic phenotype. Mechanistically, Malat1 knockdown led to decreased expression of Clec16a, silencing of which phenocopied the regulatory effect of Malat1 on M1 activation. Interestingly, Malat1 knockdown promoted IL-4 induction of mitochondrial pyruvate carriers (MPCs) and their mediation of glucose-derived oxidative phosphorylation (OxPhos), which was crucial to the Malat1 regulation of M2 differentiation and profibrotic phenotype. Furthermore, mice with either global or conditional myeloid knockout of Malat1 demonstrated diminished LPS-induced systemic and pulmonary inflammation and injury. In contrast, these mice developed more severe bleomycin-induced lung fibrosis, accompanied by alveolar macrophages displaying augmented M2 and profibrotic phenotypes. In summary, we have identified what we believe is a previously unrecognized role of Malat1 in the regulation of macrophage polarization. Our data demonstrate that Malat1 is involved in pulmonary pathogeneses in association with aberrant macrophage activation.
- Published
- 2019
- Full Text
- View/download PDF
29. Spectrum of interstitial lung disease in China from 2000 to 2012.
- Author
-
Ban C, Yan W, Xie B, Zhu M, Liu Y, Zhang S, Ye Q, Ren Y, Jiang D, Geng J, Dai H, and Wang C
- Subjects
- Adult, Aged, Beijing epidemiology, Female, Humans, Male, Middle Aged, Lung Diseases, Interstitial epidemiology, Lung Diseases, Interstitial etiology
- Abstract
Competing Interests: Conflict of interest: None declared.
- Published
- 2018
- Full Text
- View/download PDF
30. Pulmonary fibrosis in a mouse model of sarcoid granulomatosis induced by booster challenge with Propionibacterium acnes.
- Author
-
Jiang D, Huang X, Geng J, Dong R, Li S, Liu Z, Wang C, and Dai H
- Subjects
- Animals, Disease Progression, Mice, Mice, Inbred C57BL, Propionibacterium acnes, Disease Models, Animal, Gram-Positive Bacterial Infections complications, Pulmonary Fibrosis etiology, Sarcoidosis, Pulmonary complications, Sarcoidosis, Pulmonary microbiology
- Abstract
Pulmonary fibrosis (PF) associated with chronic sarcoidosis remains poorly understood, and no experimental model is currently available for this condition. Previous studies have shown that Propionibacterium acnes (PA) was associated with sarcoidosis and induced granuloma formation in mice. Here, we investigated whether repeated challenge with PA induces persistent inflammation leading to sarcoidosis followed by PF in mice. Specifically, C57BL/6 mice were inoculated intraperitoneally and subjected to intratracheal challenge with PA, and then were booster-challenged with either PA or phosphate-buffered saline on day 28. Inflammation, granulomata, and features of fibrosis were evaluated every 7 days until day 70. Complete remission of lung granulomata was apparent on day 42 in the sarcoid-remission group. However, granulomata was present from days 21 to 70 in mice that received PA boosting. Inflammatory cell counts and Th1 cytokine levels in lung lavage fluids were elevated up to day 70. Furthermore, fibrotic changes in the lungs were observed around granulomatous and peribronchovascular regions after PA boosting. Taken together, these findings suggest that development of PF following sarcoidosis may result from continuous PA infection and inflammation. Repeated boosting with PA to induce PF might be a useful model for future studies of sarcoidosis-associated PF., Competing Interests: The authors declare no conflict of interest for this work.
- Published
- 2016
- Full Text
- View/download PDF
31. Pendrin, an anion exchanger on lung epithelial cells, could be a novel target for lipopolysaccharide-induced acute lung injury mice.
- Author
-
Jia CE, Jiang D, Dai H, Xiao F, and Wang C
- Abstract
Objective: The aim of this study is to evaluate the role of pendrin in acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) and to explore whether pendrin expression existing on alveolar cells., Methods: ALI C57BL/6 mice model induced by lipopolysaccharide (LPS) was established. The expression of pendrin in lung was analyzed by RT-PCR and western blotting methods, the changes of lung inflammatory parameters and pathology were observed, the cellular distribution of pendrin in the lung was determined using immunofluorescence. Statistical comparisons between groups were made by two-tailed Student's t-test., Results: Enhanced expression of the slc26a4 gene and production of pendrin in lungs of LPS-induced ALI mice were confirmed. In comparison with vehicle-control mice, methazolamide treatment mitigated lung inflammatory parameters and pathology. IL-6 and MCP-1 in lung tissues and BALF in methazolamide-treated mice were statistically decreased. Methazolamide treatment had significant effect on the total protein concentration in the BALF and the ratio of lung wet/dry weight. The percentage of macrophages in the BALF was increased. There was a low expression of pendrin in ATII., Conclusions: Pendrin may be involved in pathological process of LPS-induced ALI. Inhibition of the pendrin function could be used to treat ALI. Airway epithelial cell may be a valuable therapeutic target for discovering and developing new drugs and/or new therapeutic strategies for the treatment of ALI/ARDS.
- Published
- 2016
32. Down-regulation of USP13 mediates phenotype transformation of fibroblasts in idiopathic pulmonary fibrosis.
- Author
-
Geng J, Huang X, Li Y, Xu X, Li S, Jiang D, Liang J, Jiang D, Wang C, and Dai H
- Subjects
- Adult, Blotting, Western, Case-Control Studies, Cell Line, Cell Movement, Cell Proliferation, Down-Regulation, Endopeptidases genetics, Fibroblasts pathology, Fluorescent Antibody Technique, Gene Expression Profiling methods, Humans, Idiopathic Pulmonary Fibrosis genetics, Idiopathic Pulmonary Fibrosis pathology, Immunoprecipitation, Lung pathology, Male, Middle Aged, Oligonucleotide Array Sequence Analysis, PTEN Phosphohydrolase metabolism, Phenotype, Proteolysis, RNA Interference, Real-Time Polymerase Chain Reaction, Reverse Transcriptase Polymerase Chain Reaction, Signal Transduction, Time Factors, Transfection, Ubiquitin-Specific Proteases, Ubiquitination, Cell Differentiation, Endopeptidases metabolism, Epithelial-Mesenchymal Transition, Fibroblasts enzymology, Idiopathic Pulmonary Fibrosis enzymology, Lung enzymology
- Abstract
Background: Idiopathic pulmonary fibrosis (IPF) is a fatal disease characterized by fibroblastic foci and progressive scarring of the pulmonary parenchyma. IPF fibroblasts display increased proliferation and enhanced migration and invasion, analogous to cancer cells. This transformation-like phenotype of fibroblasts plays an important role in the development of pulmonary fibrosis, but the mechanism for this is not well understood., Methods: In this study, we compared gene expression profiles in fibrotic lung tissues from IPF patients and normal lung tissues from patients with primary spontaneous pneumothorax using a cDNA microarray to examine the mechanisms involved in the pathogenesis of IPF. In a cDNA microarray, we found that USP13 was decreased in lung tissues from patients with IPF, which was further confirmed by results from immunohistochemistry and western blot assays. Then, we used RNA interference in MRC-5 cells to inhibit USP13 and evaluated its effects by western blot, real-time RT-PCR, bromodeoxyuridine incorporation, and transwell assays. We also used co-immunoprecipitation and immunofluorescence staining to identify the correlation between USP13 and PTEN in IPF., Results: USP13 expression levels were markedly reduced in fibroblastic foci and primary IPF fibroblast lines. The depletion of USP13 resulted in the transformation of fibroblasts into an aggressive phenotype with enhanced proliferative, migratory, and invasive capacities. Additionally, USP13 interacted with PTEN and mediated PTEN ubiquitination and degradation in lung fibroblasts., Conclusions: Down-regulation of USP13 mediates PTEN protein loss and fibroblast phenotypic change, and thereby plays a crucial role in IPF pathogenesis.
- Published
- 2015
- Full Text
- View/download PDF
33. [Role and underlying mechanism of IGF-I/ERK signaling pathway in lung fibrosis].
- Author
-
Li S, Xu X, Geng J, Huang X, Jiang D, Zhu M, and Dai H
- Subjects
- Blotting, Western, Cell Line, Tumor, Enzyme-Linked Immunosorbent Assay, Extracellular Signal-Regulated MAP Kinases, Humans, Insulin-Like Growth Factor I, Matrix Metalloproteinase 2, Matrix Metalloproteinase 9, RNA, Messenger, MAP Kinase Signaling System
- Abstract
Objective: To explore the role and underlying mechanisms of insulin-like growth factor I (IGF-I)/extracellular signal-regulated kinase (ERK) signaling pathway in lung fibrosis., Methods: Alveolar epithelial cell A549 was used. The expressions of matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9) in A549 culture media stimulated by IGF-I were determined by enzyme-linked immunosorbent assay (ELISA). ERK inhibitor U0126 was used. And there were three groups of control, IGF-I stimulation and RK inhibitor plus IGF-I stimulation. The activity of ERK in three groups was measured by Western blot. The mRNA level and protein concentration of MMP-2 and MMP-9 in three groups were examined by quantitative real-time-polymerase chain reaction (qRT-PCR) and ELISA., Results: The protein concentrations of MMP-2 and MMP-9 in cell culture media increased in 50, 100 ng/ml IGF-I groups as compared with 0 ng/ml IGF-I group ((18.30 ± 0.11), (21.80 ± 0.09) vs (13.52 ± 0.19) ng/ml and (0.34 ± 0.01), (0.39 ± 0.01) vs (0.25 ± 0.01) ng/ml, P < 0.001). And the protein concentrations of MMP-2 and MMP-9 in 100 ng/ml IGF-I group increased versus 50 ng/ml IGF-I group (P < 0.01). IGF-I stimulation group increased the expression of p-ERK1/2 versus control group (0.40 ± 0.01 vs 0.23 ± 0.02, P < 0.05) while ERK inhibitor plus IGF-I stimulation group decreased the expression of p-ERK1/2 versus IGF-I stimulation group (0.14 ± 0.03 vs 0.40 ± 0.01, P < 0.01). ERK inhibitor plus IGF-I stimulation group inhibited the mRNA levels of MMP-2 and MMP-9 versus IGF-I stimulation group (0.88 ± 0.03 vs 1.17 ± 0.05 and 0.82 ± 0.23 vs 1.81 ± 0.27, both P < 0.05) and decreased the concentrations of MMP-2 and MMP-9 in culture media versus IGF-I stimulation group ((21.70 ± 0.32) vs (29.15 ± 0.34) ng/ml and (0.22 ± 0.01) vs (0.29 ± 0.01) ng/ml, both P < 0.01)., Conclusions: IGF-I induces the expressions of MMP-2 and MMP-9 in alveolar epithelial cell through ERK signaling pathway. And it is associated with the disruption of epithelial basement membrane and the development of lung fibrosis.
- Published
- 2015
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.